Julie A. Rizzo
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Julie A. Rizzo has a total of 105 co-authors. Here are the top co-authors by number of shared publications:
- Steven Gremel Schauer
US Army Institute of Surgical Research, JBSA Fort Sam Houston, Texas, USA
6 shared publications Michael D April
Department of Emergency Medicine, Brooke Army Medical Center, JBSA Fort Sam Houston , TX 78234
4 shared publicationsJose Salinas
United States Army Institute of Surgical Research , Fort Sam Houston, TX
3 shared publicationsMatthew P. Rowan
United States Army Institute of Surgical Research, Fort Sam Houston, TX, United States
3 shared publicationsMichael A Meledeo
US Army Institute of Surgical Research, JBSA Fort Sam Houston , TX 78234
3 shared publicationsAmit Aurora
U.S. Army Institute of Surgical Research, JBSA, Fort Sam Houston, TX, United States
2 shared publications
Latest Publications
- 1 October 2026
- Published by Oxford University Press (OUP) in Military Medicine
A Scoping Review of Inhaled Methoxyflurane for Acute Traumatic Pain
Introduction: Acute pain after trauma remains a major challenge in emergency department, prehospital, and operational medicine settings. Methoxyflurane, an inhaled anesthetic first developed in the 1960s but later withdrawn due to dose-related nephrotoxicity, has been repurposed internationally at substantially lower sub-anesthetic doses as an analgesic delivered via a compact, hand-held inhaler. This review aims to characterize the available evidence regarding its efficacy, safety, and operational applications for adoption in U.S. civilian and military trauma systems. Materials and Methods: A scoping review was conducted using the PRISMA-ScR checklist. PubMed and Google Scholar were used to identify relevant literature from 1960 to 2025. Studies were eligible if they reported on the use of methoxyflurane for acute traumatic pain. Our initial search yielded 31 potential studies, of which 22 met inclusion for this review. Of those, there were 5 systematic reviews, 13 randomized controlled trials, 2 prospective observational studies, and 2 retrospective observational studies. There were 2 articles that focused on the pediatric population. Two trials are currently ongoing, 1 a systematic review comparing speed to onset of pain relief of methoxyflurane vs. the usual care and another study analyzing use and effectiveness in prehospital helicopter transport. Results: Across studies, methoxyflurane consistently demonstrated clinically meaningful rapid analgesia onset and greater efficacy than placebo and other standard selected analgesic strategies, particularly within the first 10-20 minutes. Available short-term safety data at contemporary analgesic dosages were reassuring, with few adverse events, primarily mild and transient side effects. Studies also confirmed effective patient self-administration of methoxyflurane with minimal occupational exposure risk. Conclusion: Current evidence suggests that methoxyflurane is an effective, well-tolerated, and rapid-acting analgesic for acute trauma. Current evidence supports short-term, episodic use within approved dosing limits, with favorable safety data in both adult and pediatric populations. The favorable safety profile, ease of self-administration, and non-opioid mechanism make it a potentially valuable therapy in emergency and prehospital settings. Future studies should assess usability, safety, and efficacy of methoxyflurane to define its operational use in the prehospital deployed combat setting.
- 1 October 2026
- Published by Oxford University Press (OUP) in Military Medicine
A Scoping Review of Inhaled Methoxyflurane for Acute Traumatic Pain
Introduction: Acute pain after trauma remains a major challenge in emergency department, prehospital, and operational medicine settings. Methoxyflurane, an inhaled anesthetic first developed in the 1960s but later withdrawn due to dose-related nephrotoxicity, has been repurposed internationally at substantially lower sub-anesthetic doses as an analgesic delivered via a compact, hand-held inhaler. This review aims to characterize the available evidence regarding its efficacy, safety, and operational applications for adoption in U.S. civilian and military trauma systems. Materials and Methods: A scoping review was conducted using the PRISMA-ScR checklist. PubMed and Google Scholar were used to identify relevant literature from 1960 to 2025. Studies were eligible if they reported on the use of methoxyflurane for acute traumatic pain. Our initial search yielded 31 potential studies, of which 22 met inclusion for this review. Of those, there were 5 systematic reviews, 13 randomized controlled trials, 2 prospective observational studies, and 2 retrospective observational studies. There were 2 articles that focused on the pediatric population. Two trials are currently ongoing, 1 a systematic review comparing speed to onset of pain relief of methoxyflurane vs. the usual care and another study analyzing use and effectiveness in prehospital helicopter transport. Results: Across studies, methoxyflurane consistently demonstrated clinically meaningful rapid analgesia onset and greater efficacy than placebo and other standard selected analgesic strategies, particularly within the first 10-20 minutes. Available short-term safety data at contemporary analgesic dosages were reassuring, with few adverse events, primarily mild and transient side effects. Studies also confirmed effective patient self-administration of methoxyflurane with minimal occupational exposure risk. Conclusion: Current evidence suggests that methoxyflurane is an effective, well-tolerated, and rapid-acting analgesic for acute trauma. Current evidence supports short-term, episodic use within approved dosing limits, with favorable safety data in both adult and pediatric populations. The favorable safety profile, ease of self-administration, and non-opioid mechanism make it a potentially valuable therapy in emergency and prehospital settings. Future studies should assess usability, safety, and efficacy of methoxyflurane to define its operational use in the prehospital deployed combat setting.
- 16 April 2026
- Published by Oxford University Press (OUP) in Military Medicine
- Vol. 191 (5-6) , 99-100
An Analysis of the Presence of Coagulopathy on Arrival to Emergency Departments in Deployed Military Treatment Facilities—In Response
- 16 April 2026
- Published by Oxford University Press (OUP) in Military Medicine
- Vol. 191 (5-6) , 99-100
An Analysis of the Presence of Coagulopathy on Arrival to Emergency Departments in Deployed Military Treatment Facilities—In Response
- 5 February 2026
- Published by Oxford University Press (OUP) in Military Medicine
- Vol. 191 (11-12) , e2299-e2304
A Scoping Review on Military Airway Studies
Introduction: Airway compromise is an urgent and life-threatening challenge that commonly occurs on the battlefield. Effective airway management on the battlefield is critical for reducing preventable deaths. This review summarizes the existing literature on airway management in the deployed combat setting. Materials and Methods: We conducted a scoping review using the PRISMA-ScR checklist. We used PubMed and Google Scholar to identify relevant literature from 2001 to 2025 which reflects the years for the Global War On Terrorism. Studies were eligible if they reported on airway interventions in the combat setting. Results: There were 30 airway studies that met inclusion for this review. Of the studies included in this review, 3 were focused on endotracheal intubation (ETI), 3 were focused on cricothyrotomy, 1 was focused on supraglottic airways, and 23 evaluated more than 1 airway method. The studies included 4 prospective observational studies, and 25 retrospective observational studies. Overall, ETI was the most commonly reported airway procedure with the majority performed by medical officers in both the fixed and prehospital settings. Cricothyrotomy was the second most commonly reported with a relatively low incidence and high complication. Multiple studies highlighted gaps in skills training as well as technology as a complicating factors. Conclusions: Effective airway management is critical for reducing preventable deaths on the battlefield. Endotracheal intubation is the most common advanced airway intervention, while cricothyrotomy and supraglottic airways are less common and show variable success. Ongoing gaps in training, documentation, and equipment access highlight the need for standardized airway protocols and improved training programs to improve battlefield survival among casualties requiring an advanced airway.
- 5 February 2026
- Published by Oxford University Press (OUP) in Military Medicine
- Vol. 191 (11-12) , e2299-e2304
A Scoping Review on Military Airway Studies
Introduction: Airway compromise is an urgent and life-threatening challenge that commonly occurs on the battlefield. Effective airway management on the battlefield is critical for reducing preventable deaths. This review summarizes the existing literature on airway management in the deployed combat setting. Materials and Methods: We conducted a scoping review using the PRISMA-ScR checklist. We used PubMed and Google Scholar to identify relevant literature from 2001 to 2025 which reflects the years for the Global War On Terrorism. Studies were eligible if they reported on airway interventions in the combat setting. Results: There were 30 airway studies that met inclusion for this review. Of the studies included in this review, 3 were focused on endotracheal intubation (ETI), 3 were focused on cricothyrotomy, 1 was focused on supraglottic airways, and 23 evaluated more than 1 airway method. The studies included 4 prospective observational studies, and 25 retrospective observational studies. Overall, ETI was the most commonly reported airway procedure with the majority performed by medical officers in both the fixed and prehospital settings. Cricothyrotomy was the second most commonly reported with a relatively low incidence and high complication. Multiple studies highlighted gaps in skills training as well as technology as a complicating factors. Conclusions: Effective airway management is critical for reducing preventable deaths on the battlefield. Endotracheal intubation is the most common advanced airway intervention, while cricothyrotomy and supraglottic airways are less common and show variable success. Ongoing gaps in training, documentation, and equipment access highlight the need for standardized airway protocols and improved training programs to improve battlefield survival among casualties requiring an advanced airway.
- 19 August 2025
- Published by Oxford University Press (OUP) in Military Medicine
- Vol. 191 (3-4) , e756-e762
An Analysis of the Presence of Coagulopathy on Arrival to Emergency Departments in Deployed Military Treatment Facilities
Introduction: Acute traumatic coagulopathy remains a high predictor of mortality; however, the incidence and outcomes in the military population have limited data. The goal of our study is to characterize coagulopathy on arrival to deployed Role 2 and Role 3 Military Treatment Facilities (MTFs). Materials and Methods: We utilized the Department of Defense Trauma Registry to identify United States (U.S.) military, Coalition forces, and U.S. contractors with documentation of international normalized ratio (INR) in the emergency department. We defined coagulopathy as INR of ≥1.6 based on Youden’s index, with INR as the independent variable and 24-hour survival as the outcome variable. We constructed multivariable logistic regression models with coagulopathy as the outcome variable to test for associations. Results: There were 13,015 encounters that met inclusion for our primary analysis. Based on the receiver operating characteristic (ROC) analysis, coagulopathy was defined as ≥1.6 (area under the ROC = 0.862). Using this threshold, 999 patients met criteria for coagulopathy. Explosions were the predominate mechanism among both groups (69% among those with coagulopathy vs. 59%, P < 0.001). Median composite injury severity scores were 24 (11-33) among those with coagulopathy versus 6 (3-13, P < 0.001). The body regions most frequently sustaining serious injuries were the head/neck (29% vs. 9%) and the extremities (47% vs. 22%, P < 0.001). Survival was lower at 24 hours (91% vs. 99%) and discharge (83% vs. 99%, P < 0.001). In our adjusted model, serious injuries to the head/neck (odds ratio [OR] 3.61, 95% confidence interval [CI] 3.05-4.26) and skin (3.88, 2.94-5.11) were most associated with coagulopathy. Prehospital blood administration (OR 1.08, 0.73-1.61) and fluid administration (1.03, 0.77-1.37) were not associated. Conclusions: Nearly 1 in 12 casualties within our dataset had evidence of coagulopathy on arrival to deployed MTFs with surgical capabilities. Our will help guide future research efforts.
- 19 August 2025
- Published by Oxford University Press (OUP) in Military Medicine
- Vol. 191 (3-4) , e756-e762
An Analysis of the Presence of Coagulopathy on Arrival to Emergency Departments in Deployed Military Treatment Facilities
Introduction: Acute traumatic coagulopathy remains a high predictor of mortality; however, the incidence and outcomes in the military population have limited data. The goal of our study is to characterize coagulopathy on arrival to deployed Role 2 and Role 3 Military Treatment Facilities (MTFs). Materials and Methods: We utilized the Department of Defense Trauma Registry to identify United States (U.S.) military, Coalition forces, and U.S. contractors with documentation of international normalized ratio (INR) in the emergency department. We defined coagulopathy as INR of ≥1.6 based on Youden’s index, with INR as the independent variable and 24-hour survival as the outcome variable. We constructed multivariable logistic regression models with coagulopathy as the outcome variable to test for associations. Results: There were 13,015 encounters that met inclusion for our primary analysis. Based on the receiver operating characteristic (ROC) analysis, coagulopathy was defined as ≥1.6 (area under the ROC = 0.862). Using this threshold, 999 patients met criteria for coagulopathy. Explosions were the predominate mechanism among both groups (69% among those with coagulopathy vs. 59%, P < 0.001). Median composite injury severity scores were 24 (11-33) among those with coagulopathy versus 6 (3-13, P < 0.001). The body regions most frequently sustaining serious injuries were the head/neck (29% vs. 9%) and the extremities (47% vs. 22%, P < 0.001). Survival was lower at 24 hours (91% vs. 99%) and discharge (83% vs. 99%, P < 0.001). In our adjusted model, serious injuries to the head/neck (odds ratio [OR] 3.61, 95% confidence interval [CI] 3.05-4.26) and skin (3.88, 2.94-5.11) were most associated with coagulopathy. Prehospital blood administration (OR 1.08, 0.73-1.61) and fluid administration (1.03, 0.77-1.37) were not associated. Conclusions: Nearly 1 in 12 casualties within our dataset had evidence of coagulopathy on arrival to deployed MTFs with surgical capabilities. Our will help guide future research efforts.
- 14 June 2025
- Published by Oxford University Press (OUP) in Military Medicine
- Vol. 191 (1-2) , e85-e94
A Narrative Review of Erythropoietin Stimulating Agents for Trauma
Introduction: Erythropoietin Stimulating Agents (ESAs), analogs of an endogenous hormone, have been extensively studied in clinical and research medicine since being made in a recombinant form over forty years. They have several indications for chronic anemia. In the critically injured trauma population, ESAs have been examined for their potential red blood cell transfusion-sparing effects. However, the literature to date does not support ESAs use in avoiding transfusion. Instead, the focus of their use has shifted to their extra-hematopoietic effects, which may reduce mortality and improve neurologic outcomes in severely injured patients. This narrative review aims to detail the current state of data on using ESAs in the major trauma population. Materials and Methods: Our review followed the guidelines established by the Preferred Reporting Items for Systematic Reviews and Meta-Analysis-Scoping Reviews. The primary author used PubMed and Dynamed databases for terms related to erythropoietin (or ESAs) and the trauma population. Abstracts from peer-reviewed articles from 1999 to 2024 were screened for relevant material regarding the above criteria, followed by an article review if selected for inclusion. Results: We screened 582 studies, of which 46 met the inclusion criteria for this review. There were 9 RCTs, 24 meta-analyses/systematic reviews, 7 retrospective studies, 1 prospective observational study, and 4 preclinical/basic science articles were used. Of these, 12 demonstrated a potential benefit with the use of ESAs with improved mortality. There were 7 that demonstrated no increased adverse events. Conclusion: Erythropoietin Stimulating Agents have been evaluated as a viable treatment option that may improve morbidity and mortality in patients with major trauma, particularly in the setting of traumatic brain injury and severe physical injury. This scoping review of 46 studies underscores the potential benefits of ESAs, indicating a need for further research.
- 14 June 2025
- Published by Oxford University Press (OUP) in Military Medicine
- Vol. 191 (1-2) , e85-e94
A Narrative Review of Erythropoietin Stimulating Agents for Trauma
Introduction: Erythropoietin Stimulating Agents (ESAs), analogs of an endogenous hormone, have been extensively studied in clinical and research medicine since being made in a recombinant form over forty years. They have several indications for chronic anemia. In the critically injured trauma population, ESAs have been examined for their potential red blood cell transfusion-sparing effects. However, the literature to date does not support ESAs use in avoiding transfusion. Instead, the focus of their use has shifted to their extra-hematopoietic effects, which may reduce mortality and improve neurologic outcomes in severely injured patients. This narrative review aims to detail the current state of data on using ESAs in the major trauma population. Materials and Methods: Our review followed the guidelines established by the Preferred Reporting Items for Systematic Reviews and Meta-Analysis-Scoping Reviews. The primary author used PubMed and Dynamed databases for terms related to erythropoietin (or ESAs) and the trauma population. Abstracts from peer-reviewed articles from 1999 to 2024 were screened for relevant material regarding the above criteria, followed by an article review if selected for inclusion. Results: We screened 582 studies, of which 46 met the inclusion criteria for this review. There were 9 RCTs, 24 meta-analyses/systematic reviews, 7 retrospective studies, 1 prospective observational study, and 4 preclinical/basic science articles were used. Of these, 12 demonstrated a potential benefit with the use of ESAs with improved mortality. There were 7 that demonstrated no increased adverse events. Conclusion: Erythropoietin Stimulating Agents have been evaluated as a viable treatment option that may improve morbidity and mortality in patients with major trauma, particularly in the setting of traumatic brain injury and severe physical injury. This scoping review of 46 studies underscores the potential benefits of ESAs, indicating a need for further research.
- 9 April 2025
- Published by Oxford University Press (OUP) in Journal of Burn Care & Research
- Vol. 46 (4) , 850-853
Decrease in Total Leukocyte Count is Associated with Acute Kidney Injury After Severe Burn
Leukocytosis is common after burn injury from profound systemic inflammatory response. Total leukocyte count (TLC) often decreases 72-96 h post-injury. The incidence of early (20% TBSA and >40 kg that were resuscitated utilizing the BN clinical decision support system. Patients were split into 2 groups based on a decrease in TLC from admission of greater than versus less than 15 000 cells per microliter. Demographics, resuscitation volumes, resuscitation-related complications, and 7-day survival were collected. Of the 295 patients in the analysis, patients with greater than the 15-point decrease in WBC from admission had more full-thickness burns (14.2 [2, 36]) and greater TBSA (41 [30.2, 57.4]) than those with less than a 15-point decrease (7.7 [0.3, 14.8], P < .001), 27.5 [23, 36], P < .001. Patients with greater than a 15-point WBC drop had a significantly higher incidence of admission myoglobinuria and AKI in the first 48 h even after adjusting for TBSA. Survival at 7 days did not differ (66.7% vs. 83.7%, P > .05) when adjusting for TBSA. A decrease in WBC of at least 15 points after admission was associated with early AKI and a significantly higher incidence of admission myoglobinuria. Future studies need to investigate the mechanism behind this association and possible early interventions.
- 9 April 2025
- Published by Oxford University Press (OUP) in Journal of Burn Care & Research
- Vol. 46 (4) , 850-853
Decrease in Total Leukocyte Count is Associated with Acute Kidney Injury After Severe Burn
Leukocytosis is common after burn injury from profound systemic inflammatory response. Total leukocyte count (TLC) often decreases 72-96 h post-injury. The incidence of early (20% TBSA and >40 kg that were resuscitated utilizing the BN clinical decision support system. Patients were split into 2 groups based on a decrease in TLC from admission of greater than versus less than 15 000 cells per microliter. Demographics, resuscitation volumes, resuscitation-related complications, and 7-day survival were collected. Of the 295 patients in the analysis, patients with greater than the 15-point decrease in WBC from admission had more full-thickness burns (14.2 [2, 36]) and greater TBSA (41 [30.2, 57.4]) than those with less than a 15-point decrease (7.7 [0.3, 14.8], P < .001), 27.5 [23, 36], P < .001. Patients with greater than a 15-point WBC drop had a significantly higher incidence of admission myoglobinuria and AKI in the first 48 h even after adjusting for TBSA. Survival at 7 days did not differ (66.7% vs. 83.7%, P > .05) when adjusting for TBSA. A decrease in WBC of at least 15 points after admission was associated with early AKI and a significantly higher incidence of admission myoglobinuria. Future studies need to investigate the mechanism behind this association and possible early interventions.
- 26 July 2022
- Published by Oxford University Press (OUP) in Journal of Burn Care & Research
- Vol. 44 (2) , 446-451
The Battle of the Titans—Comparing Resuscitation Between Five Major Burn Centers Using the Burn Navigator
The goal of burn resuscitation is to provide the optimal amount of fluid necessary to maintain end-organ perfusion and prevent burn shock. The objective of this analysis was to examine how the Burn Navigator (BN), a clinical decision support tool in burn resuscitation, was utilized across five major burn centers in the United States, using an observational trial of 300 adult patients. Subject demographics, burn characteristics, fluid volumes, urine output, and resuscitation-related complications were examined. Two hundred eighty-five patients were eligible for analysis. There was no difference among the centers on mean age (45.5 ± 16.8 years), body mass index (29.2 ± 6.9), median injury severity score (18 [interquartile range: 9–25]), or total body surface area (TBSA) (34 [25.8–47]). Primary crystalloid infusion volumes at 24 h differed significantly in ml/kg/TBSA (range: 3.1 ± 1.2 to 4.5 ± 1.7). Total fluids, including colloid, drip medications, and enteral fluids, differed among centers in both ml/kg (range: 132.5 ± 61.4 to 201.9 ± 109.9) and ml/kg/TBSA (3.5 ± 1.0 to 5.3 ± 2.0) at 24 h. Post-hoc adjustment using pairwise comparisons resulted in a loss of significance between most of the sites. There was a total of 156 resuscitation-related complications in 92 patients. Experienced burn centers using the BN successfully titrated resuscitation to adhere to 24 h goals. With fluid volumes near the Parkland formula prediction and a low prevalence of complications, the device can be utilized effectively in experienced centers. Further study should examine device utility in other facilities and on the battlefield.
- 26 July 2022
- Published by Oxford University Press (OUP) in Journal of Burn Care & Research
- Vol. 44 (2) , 446-451
The Battle of the Titans—Comparing Resuscitation Between Five Major Burn Centers Using the Burn Navigator
The goal of burn resuscitation is to provide the optimal amount of fluid necessary to maintain end-organ perfusion and prevent burn shock. The objective of this analysis was to examine how the Burn Navigator (BN), a clinical decision support tool in burn resuscitation, was utilized across five major burn centers in the United States, using an observational trial of 300 adult patients. Subject demographics, burn characteristics, fluid volumes, urine output, and resuscitation-related complications were examined. Two hundred eighty-five patients were eligible for analysis. There was no difference among the centers on mean age (45.5 ± 16.8 years), body mass index (29.2 ± 6.9), median injury severity score (18 [interquartile range: 9–25]), or total body surface area (TBSA) (34 [25.8–47]). Primary crystalloid infusion volumes at 24 h differed significantly in ml/kg/TBSA (range: 3.1 ± 1.2 to 4.5 ± 1.7). Total fluids, including colloid, drip medications, and enteral fluids, differed among centers in both ml/kg (range: 132.5 ± 61.4 to 201.9 ± 109.9) and ml/kg/TBSA (3.5 ± 1.0 to 5.3 ± 2.0) at 24 h. Post-hoc adjustment using pairwise comparisons resulted in a loss of significance between most of the sites. There was a total of 156 resuscitation-related complications in 92 patients. Experienced burn centers using the BN successfully titrated resuscitation to adhere to 24 h goals. With fluid volumes near the Parkland formula prediction and a low prevalence of complications, the device can be utilized effectively in experienced centers. Further study should examine device utility in other facilities and on the battlefield.
- Open Access
Spectral Reflectance as a Unique Tissue Identifier in Healthy Humans and Inhalation Injury Subjects
Tracheal intubation is the preferred method of airway management, a common emergency trauma medicine problem. Currently, methods for confirming tracheal tube placement are lacking, and we propose a novel technology, spectral reflectance, which may be incorporated into the tracheal tube for verification of placement. Previous work demonstrated a unique spectral profile in the trachea, which allowed differentiation from esophageal tissue in ex vivo swine, in vivo swine, and human cadavers. The goal of this study is to determine if spectral reflectance can differentiate between trachea and other airway tissues in living humans and whether the unique tracheal spectral profile persists in the presence of an inhalation injury. Reflectance spectra were captured using a custom fiber-optic probe from the buccal mucosa, posterior oropharynx, and trachea of healthy humans intubated for third molar extraction and from the trachea of patients admitted to a burn intensive care unit with and without inhalation injury. Using ratio comparisons, we found that the tracheal spectral profile was significantly different from buccal mucosa or posterior oropharynx, but the area under the curve values are not high enough to be used clinically. In addition, inhalation injury did not significantly alter the spectral reflectance of the trachea. Further studies are needed to determine the utility of this technology in a clinical setting and to develop an algorithm for tissue differentiation.
Open AccessSpectral Reflectance as a Unique Tissue Identifier in Healthy Humans and Inhalation Injury Subjects
Tracheal intubation is the preferred method of airway management, a common emergency trauma medicine problem. Currently, methods for confirming tracheal tube placement are lacking, and we propose a novel technology, spectral reflectance, which may be incorporated into the tracheal tube for verification of placement. Previous work demonstrated a unique spectral profile in the trachea, which allowed differentiation from esophageal tissue in ex vivo swine, in vivo swine, and human cadavers. The goal of this study is to determine if spectral reflectance can differentiate between trachea and other airway tissues in living humans and whether the unique tracheal spectral profile persists in the presence of an inhalation injury. Reflectance spectra were captured using a custom fiber-optic probe from the buccal mucosa, posterior oropharynx, and trachea of healthy humans intubated for third molar extraction and from the trachea of patients admitted to a burn intensive care unit with and without inhalation injury. Using ratio comparisons, we found that the tracheal spectral profile was significantly different from buccal mucosa or posterior oropharynx, but the area under the curve values are not high enough to be used clinically. In addition, inhalation injury did not significantly alter the spectral reflectance of the trachea. Further studies are needed to determine the utility of this technology in a clinical setting and to develop an algorithm for tissue differentiation.
- Open Access
- 15 October 2021
- Published by Oxford University Press (OUP) in Journal of Burn Care & Research
- Vol. 43 (3) , 728-734
Initial Results of the American Burn Association Observational Multicenter Evaluation on the Effectiveness of the Burn Navigator
The objective of this multicenter observational study was to evaluate resuscitation volumes and outcomes of patients who underwent fluid resuscitation utilizing the Burn Navigator (BN), a resuscitation clinical decision support tool. Two analyses were performed: examination of the first 24 hours of resuscitation and the first 24 hours postburn regardless of when the resuscitation began, to account for patients who presented in a delayed fashion. Patients were classified as having followed the BN (FBN) if all hourly fluid rates were within ±20 ml of BN recommendations for that hour at least 83% of the time; otherwise, they were classified as not having followed BN (NFBN). Analysis of resuscitation volumes for FBN patients in the first 24 hours resulted in average volumes for primary crystalloid and total fluids administered of 4.07 ± 1.76 ml/kg/TBSA (151.48 ± 77.46 ml/kg) and 4.68 ± 2.06 ml/kg/TBSA (175.01 ± 92.22 ml/kg), respectively. Patients who presented in a delayed fashion revealed average volumes for primary and total fluids of 5.28 ± 2.54 ml/kg/TBSA (201.11 ± 106.53 ml/kg) and 6.35 ± 2.95 ml/kg/TBSA (244.08 ± 133.5 ml/kg), respectively. There was a significant decrease in the incidence of burn shock in the FBN group (P < .05). This study shows that the BN provides comparable resuscitation volumes of primary crystalloid fluid to the Parkland formula, recommends total fluid infusion less than the Ivy index, and was associated with a decreased incidence of burn shock. Early initiation of the BN device resulted in lower overall fluid volumes.
- 15 October 2021
- Published by Oxford University Press (OUP) in Journal of Burn Care & Research
- Vol. 43 (3) , 728-734
Open AccessInitial Results of the American Burn Association Observational Multicenter Evaluation on the Effectiveness of the Burn Navigator
The objective of this multicenter observational study was to evaluate resuscitation volumes and outcomes of patients who underwent fluid resuscitation utilizing the Burn Navigator (BN), a resuscitation clinical decision support tool. Two analyses were performed: examination of the first 24 hours of resuscitation and the first 24 hours postburn regardless of when the resuscitation began, to account for patients who presented in a delayed fashion. Patients were classified as having followed the BN (FBN) if all hourly fluid rates were within ±20 ml of BN recommendations for that hour at least 83% of the time; otherwise, they were classified as not having followed BN (NFBN). Analysis of resuscitation volumes for FBN patients in the first 24 hours resulted in average volumes for primary crystalloid and total fluids administered of 4.07 ± 1.76 ml/kg/TBSA (151.48 ± 77.46 ml/kg) and 4.68 ± 2.06 ml/kg/TBSA (175.01 ± 92.22 ml/kg), respectively. Patients who presented in a delayed fashion revealed average volumes for primary and total fluids of 5.28 ± 2.54 ml/kg/TBSA (201.11 ± 106.53 ml/kg) and 6.35 ± 2.95 ml/kg/TBSA (244.08 ± 133.5 ml/kg), respectively. There was a significant decrease in the incidence of burn shock in the FBN group (P < .05). This study shows that the BN provides comparable resuscitation volumes of primary crystalloid fluid to the Parkland formula, recommends total fluid infusion less than the Ivy index, and was associated with a decreased incidence of burn shock. Early initiation of the BN device resulted in lower overall fluid volumes.
- Open Access
- 16 July 2021
- Published by Wiley in Transfusion
- Vol. 61 (S1) , S183-S187
Intraoperative blood transfusions in burn patients
Background: Donated blood is a valuable and limited resource. Excision of burn wounds often leads to significant blood loss requiring transfusion. Accurately estimating blood loss is difficult, so examining the amount of blood products given intraoperatively is a clinically relevant way to measure utilization of this valuable resource. In this study, we examined the factors that influenced the amount of blood given intraoperatively during burn wound excisions.Study Design and Methods: A retrospective analysis of patients admitted to a single burn center over 5 years who underwent excision of their burn wounds and received intraoperative blood products was performed. Patient and burn characteristics as well as pertinent surgical data and laboratory values on the day of surgery and postoperatively were gathered. A linear regression analysis examined factors influencing the number of units of products given and a predictive model was generated.Results: A total of 563 operations performed on 166 patients were included. The amount of burn excised was the most influential variable on the amount of blood products given. Hemoglobin level, international normalized ratio, and platelet count on the day of surgery were associated with transfusion of different blood products. A predictive model was generated to aid in preoperative ordering of blood products.Conclusion: The amount of burn excised and common hematology and coagulation lab values were associated with the amount of different blood products administered during burn surgery. The predictive model generated needs to be validated prospectively to aid in preoperative planning for burn excisions.
- 16 July 2021
- Published by Wiley in Transfusion
- Vol. 61 (S1) , S183-S187
Open AccessIntraoperative blood transfusions in burn patients
Background: Donated blood is a valuable and limited resource. Excision of burn wounds often leads to significant blood loss requiring transfusion. Accurately estimating blood loss is difficult, so examining the amount of blood products given intraoperatively is a clinically relevant way to measure utilization of this valuable resource. In this study, we examined the factors that influenced the amount of blood given intraoperatively during burn wound excisions.Study Design and Methods: A retrospective analysis of patients admitted to a single burn center over 5 years who underwent excision of their burn wounds and received intraoperative blood products was performed. Patient and burn characteristics as well as pertinent surgical data and laboratory values on the day of surgery and postoperatively were gathered. A linear regression analysis examined factors influencing the number of units of products given and a predictive model was generated.Results: A total of 563 operations performed on 166 patients were included. The amount of burn excised was the most influential variable on the amount of blood products given. Hemoglobin level, international normalized ratio, and platelet count on the day of surgery were associated with transfusion of different blood products. A predictive model was generated to aid in preoperative ordering of blood products.Conclusion: The amount of burn excised and common hematology and coagulation lab values were associated with the amount of different blood products administered during burn surgery. The predictive model generated needs to be validated prospectively to aid in preoperative planning for burn excisions.